DekaBank Deutsche Girozentrale
MGNX icon

DekaBank Deutsche Girozentrale’s MacroGenics MGNX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,300
Closed -$162K – 1405
2022
Q1 		$162K Buy
18,300
+1,700
+10% +$18.8K ﹤0.01% 1238
2021
Q4 		$261K Buy
16,600
+400
+2% +$7.53K ﹤0.01% 1224
2021
Q3 		$330K Hold
16,200
– – ﹤0.01% 1122
2021
Q2 		$426K Hold
16,200
– – ﹤0.01% 1102
2021
Q1 		$503K Hold
16,200
– – ﹤0.01% 1031
2020
Q4 		$363K Buy
16,200
+6,200
+62% +$143K ﹤0.01% 1086
2020
Q3 		$251K Buy
+10,000
New +$273K ﹤0.01% 1015
2019
Q2 		– Sell
-193,600
Closed -$4.33M – 1231
2019
Q1 		$4.33M Buy
193,600
+179,300
+1,254% +$3.1M 0.03% 451
2018
Q4 		$180K Sell
14,300
-179,300
-93% -$3.01M ﹤0.01% 981
2018
Q3 		$4.33M Buy
193,600
+175,500
+970% +$3.74M 0.03% 458
2018
Q2 		$375K Hold
18,100
– – ﹤0.01% 970
2018
Q1 		$426K Sell
18,100
-210,400
-92% -$5.11M ﹤0.01% 895
2017
Q4 		$3.75M Hold
228,500
– – 0.03% 422
2017
Q3 		$3.75M Buy
228,500
+20,000
+10% +$346K 0.03% 426
2017
Q2 		$3.65M Buy
208,500
+190,000
+1,027% +$3.62M 0.03% 438
2017
Q1 		$326K Sell
18,500
-1,500
-8% -$28.9K ﹤0.01% 802
2016
Q4 		$396K Buy
20,000
+1,500
+8% +$37.8K ﹤0.01% 698
2016
Q3 		$544K Hold
18,500
– – 0.01% 648
2016
Q2 		$498K Buy
18,500
+3,700
+25% +$83.4K 0.01% 680
2016
Q1 		$255K Sell
14,800
-2,600
-15% -$49.5K ﹤0.01% 796
2015
Q4 		$542K Buy
17,400
+500
+3% +$15.2K 0.01% 682
2015
Q3 		$362K Buy
16,900
+3,400
+25% +$107K ﹤0.01% 753
2015
Q2 		$513K Buy
13,500
+500
+4% +$16.4K 0.01% 694
2015
Q1 		$408K Buy
+13,000
New +$441K 0.01% 768

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MGNX Position: Q2 2022 in Review

DekaBank Deutsche Girozentrale sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 18,300 shares — an estimated $162K sold.

DekaBank Deutsche Girozentrale first reported a position in MGNX in Q1 2015 and held it in 24 quarters. The position peaked at $4.33M in Q1 2019. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • DekaBank Deutsche Girozentrale reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 18,300 MacroGenics shares in Q2 2022, an estimated $162K.
  • DekaBank Deutsche Girozentrale first reported a position in MacroGenics in Q1 2015 and held it in 24 quarters.
  • DekaBank Deutsche Girozentrale's MacroGenics position peaked at $4.33M in Q1 2019.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.